CIK 0001728328
- Emerging growth company
Mentari Therapeutics, Inc.
Sign in to watch- Ticker
- MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 981428279
- Phone
- +1 781-887-5080
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- InMed Pharmaceuticals Inc.
- Open-market buys, last 90 days
- $238,371
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-23 | Tegge Jonathan Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 31,400 | ||
| 2022-12-16 | Tegge Jonathan Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +1,400 | 1,400 |
Page 1 of 1 · 2 trades